- Home
- LNN vs NVCR Comparison
LNN vs NVCR Comparison
Compare LNN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNN
- NVCR
- Stock Information
- Founded
- LNN 1954
- NVCR 2000
- Country
- LNN United States
- NVCR Switzerland
- Employees
- LNN N/A
- NVCR N/A
- Industry
- LNN Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- LNN Industrials
- NVCR Health Care
- Exchange
- LNN Nasdaq
- NVCR Nasdaq
- Market Cap
- LNN 1.5B
- NVCR 1.4B
- IPO Year
- LNN 1988
- NVCR 2015
- Fundamental
- Price
- LNN $140.46
- NVCR $11.91
- Analyst Decision
- LNN Hold
- NVCR Buy
- Analyst Count
- LNN 1
- NVCR 7
- Target Price
- LNN $136.00
- NVCR $28.79
- AVG Volume (30 Days)
- LNN 76.8K
- NVCR 1.7M
- Earning Date
- LNN 10-23-2025
- NVCR 07-24-2025
- Dividend Yield
- LNN 1.03%
- NVCR N/A
- EPS Growth
- LNN 5.71
- NVCR N/A
- EPS
- LNN 6.96
- NVCR N/A
- Revenue
- LNN $677,807,000.00
- NVCR $630,160,000.00
- Revenue This Year
- LNN $13.09
- NVCR $6.68
- Revenue Next Year
- LNN N/A
- NVCR $7.01
- P/E Ratio
- LNN $20.17
- NVCR N/A
- Revenue Growth
- LNN 9.46
- NVCR 14.58
- 52 Week Low
- LNN $112.14
- NVCR $10.87
- 52 Week High
- LNN $150.96
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- LNN 53.46
- NVCR 42.42
- Support Level
- LNN $137.32
- NVCR $11.63
- Resistance Level
- LNN $143.81
- NVCR $12.47
- Average True Range (ATR)
- LNN 2.90
- NVCR 0.47
- MACD
- LNN 0.19
- NVCR 0.24
- Stochastic Oscillator
- LNN 61.54
- NVCR 65.00
About LNN Lindsay Corporation
Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.